CO-BARITEC CO-BARITEC CO-BARITEC CO-BARITEC CO-BARITEC CO-BARITEC BARITEC BARITEC ORION CA ORION CA ORION CA ORION CA ORION DIU ORION ORION ORION OMSANA AM OMSANA AM OMSANA AM OMSANA OMSANA OMSANA OSCORD OSCORD OSCORD OSCORD OSCORD OSCORD OSCORD OSCORD DIU OSCORD DIU OSCORD DIU OSCORD DIU OSCORD DIU OSCORD DIU OSCORD DIU OMSANA DIU OMSANA DIU OMSANA DIU BENICAR PLUS BENICAR PLUS BENICAR-H BENSAR BENSAR BENSAR BENSAR BENSAR OLESTA OLESTA CO-OLESTA CO-OLESTA OLMEDIP OLMEDIP OLMEDIP OLMEDIP SOFVASC-OLM SOFVASC-OLM SOFVASC-OLM SOFVASC SOFVASC SOFVASC NEGATIN NEGATIN NEGATIN NEGATIN NEGATIN OLMIPRESS -H OLMIPRESS -H OLMIPRESS -H OLMIPRESS OLMIPRESS OLMICAR OLMICAR COMCARB COMCARB COMCARB COMCARB MALISARTAN MALISARTAN MALISARTAN MALISARTAN -HT MALISARTAN -HT MALISARTAN -HT

Dose: 20 mg
Single Dose: 20 (20)
Frequency: 24 hourly
Route: PO
Instructions: For patients requiring further reduction in blood pressure after 2 weeks of therapy, the dose of Olmesartan Medoxomil may be increased to 40 mg. Doses above 40 mg do not appear to have greater effect.

. It is of Synthetic origin and belongs to Ester. . The Molecular Weight of Olmesartan Medoxomil is 558.59.

Olmesartan Medoxomil is contraindicated in conditions like Hepatic impairment,Breast feeding,Dry or painful cough,Pain and inflammation (rheumatic disease).

The symptomatic adverse reactions produced by Olmesartan Medoxomil are more or less tolerable and if they become severe, they can be treated symptomatically, these include Dizziness, Headache, Diarrhea, Pharyngitis, Hematuria, Hypotension, Rhinitis, Bronchitis, Angioedema, Sinusitis, Hyperglycemia, Back pain, dizziness, Pruritis, Hypotension.

Olmesartan Medoxomil is primarily indicated in conditions like Hypertension, and can also be given in adjunctive therapy as an alternative drug of choice in Diabetic nephropathy, Heart failure.

No data regarding the interactions of Olmesartan Medoxomil was found.

Hematocrit Value Liver Function Test (LFT) Raised creatine phosphokinaseElevated liver enzymes

Drug should not be given to Paediatrics, Pregnant Mothers, patients suffering from Kidney dysfunction, Geriatrics, and Neonates.If prescribing authority justifies the benefits of the drug against the possible damages he/she should reevaluate them and consult the reference material and previous studies.

Tabs Store Between 20°C-25°C. Protect from Moisture and Heat.

Use with caution in renal artery stenosis, aortic or mitral valve stenosis and in obstructive hypertrophic cardiomyopathy.Monitor plasma-potassium concentration, particularly in elderly and in patients with renal impairment; lower initial doses may be appropriate in these patients.